Lung Reference Set A Application: Pierre Massion-Vanderbilt (2017)

Abbreviated Name
Lung Ref Set A App: Massion (2017)
Lead Investigator
Grogan, EricVanderbilt -Ingram Cancer Center
Coordinating Investigator
Feng, Ziding Fred Hutchinson Cancer Center
Involved Investigators


No abstract availalbe.


No aims available.

Analytic Method

No analytic method available.


The CBSI measurement of CYFRA 21-1 is not observed to have discriminatory ability between lung cancer cases and high-risk controls in the dataset sampled from the EDRN Lung Reference Set A. Pre-specied analyses: -sensitivity at 80% specicity: 0:27 (95% CI 0:18; 0:37) - specicity at 80% sensitivity: 0:25 (95% CI 0:16; 0:4). Both observed values are only somewhat greater than 20% (the expected value assuming no discrimination) and 95% condence intervals do not exclude the null. The corresponding positive and negative diagnostic likelihood ratios and the overall AUC similarly do not suggest much discrimination.


  • No publications available at this time for this protocol.


Data Collections

  • No data collections available at this time for this protocol.
 Team Project
Start Date
Jun 13 2017
Estimated Finish Date
Oct 13 2017
Finish Date
Jan 2 2018
Protocol ID
Protocol Type
Reference Set
Fields of Research
Collaborative Group
Lung and Upper Aerodigestive Cancers Research Group
Cancer Types
  • Malignant neoplasm of bronchus and lung
Phased Status

Associated Forms